Literature DB >> 9306062

Estimation of performance potential of standardbred trotters from blood lactate concentrations measured in field conditions.

A Couroucé1, J C Chatard, B Auvinet.   

Abstract

The purpose of this study was to examine the relationship between V4 (velocity which results in a blood lactate concentration of 4 mmol/l), age and racing performance of Standardbred trotters and to establish V4 normal values to select good and poor performers. The specific influence of racing (RT) and training (T1 and T2) tracks was also examined. A total of 159 horses were divided into 5 age-groups from 2 to 6 and over and performed 330 standardised exercise tests of 3 steps performed at increasing speeds. The velocity of the horses was measured with a tachometer on the sulky. Blood lactate concentrations were measured from the jugular vein after each step. For the 5 age-groups, mean V4 values increased significantly (P < 0.05) with age between 2 and 4 years. After 5 years, this increase was reduced and became nonsignificant. The highest V4 values were obtained on the racing track (RT) and the lowest on the training tracks (T1; P < 0.05). No significant difference was found between RT and T2 nor between T1 and T2. Horses were defined as good performers (GP) when finishing between the first and the fifth place in a race or poor performers (PP) when finishing lower than fifth. V4 was significantly higher for GP than for PP (P < 0.05). Normal value of V4 were established for good and poor performers taking into account the 95% confidence interval of the data. Therefore, V4 depends on age and track and can be considered an important parameter to evaluate trotters' racing potential.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9306062     DOI: 10.1111/j.2042-3306.1997.tb03140.x

Source DB:  PubMed          Journal:  Equine Vet J        ISSN: 0425-1644            Impact factor:   2.888


  7 in total

1.  Locomotor response to exercise in relation to plasma lactate accumulation and heart rate in Andalusian and Anglo-Arabian horses.

Authors:  A Muñoz; R Santisteban; M D Rubio; C Riber; E I Agüera; F M Castejón
Journal:  Vet Res Commun       Date:  1999-10       Impact factor: 2.459

2.  Assessing fitness in endurance horses.

Authors:  Audrey Fraipont; Emmanuelle Van Erck; Eve Ramery; Guillaume Fortier; Pierre Lekeux; Tatiana Art
Journal:  Can Vet J       Date:  2012-03       Impact factor: 1.008

3.  A longitudinal study of poor performance and subclinical respiratory viral activity in Standardbred trotters.

Authors:  Helena Back; Johanna Penell; John Pringle; Mats Isaksson; Nils Ronéus; Louise Treiberg Berndtsson; Karl Ståhl
Journal:  Vet Rec Open       Date:  2015-06-17

4.  Reduced high intensity training distance had no effect on VLa4 but attenuated heart rate response in 2-3-year-old Standardbred horses.

Authors:  Sara Ringmark; Arne Lindholm; Ulf Hedenström; Michael Lindinger; Kristina Dahlborn; Clarence Kvart; Anna Jansson
Journal:  Acta Vet Scand       Date:  2015-03-20       Impact factor: 1.695

5.  The Relationship between Lung Inflammation and Aerobic Threshold in Standardbred Racehorses with Mild-Moderate Equine Asthma.

Authors:  Luca Stucchi; Elena Alberti; Giovanni Stancari; Bianca Conturba; Enrica Zucca; Francesco Ferrucci
Journal:  Animals (Basel)       Date:  2020-07-27       Impact factor: 2.752

6.  Associations between Exercise-Induced Pulmonary Hemorrhage (EIPH) and Fitness Parameters Measured by Incremental Treadmill Test in Standardbred Racehorses.

Authors:  Chiara Maria Lo Feudo; Luca Stucchi; Giovanni Stancari; Elena Alberti; Bianca Conturba; Enrica Zucca; Francesco Ferrucci
Journal:  Animals (Basel)       Date:  2022-02-12       Impact factor: 2.752

7.  A prospective study on a cohort of horses and ponies selected for participation in the European Eventing Championship: reasons for withdrawal and predictive value of fitness tests.

Authors:  Carolien C B M Munsters; Jan van den Broek; Emile Welling; René van Weeren; Marianne M Sloet van Oldruitenborgh-Oosterbaan
Journal:  BMC Vet Res       Date:  2013-09-13       Impact factor: 2.741

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.